Kaiser Permanente Northern California coverage for

Employer / Commercial Insurance

Covered with requirements

What you need to qualify

Age 18 and older
BMI of 30 or higher
BMI of 27.5 or higher for patients of Asian descent
6 months of a documented diet and exercise program
Diagnosed obstructive sleep apnea (AHI of 15 or higher), with a documented trial of PAP therapy

Qualification pathways

You can qualify through any one of these.

Initial approval for moderate to severe OSA

All of:

Diagnosis of moderate to severe obstructive sleep apnea
AHI/RDI/REI of at least 15 events per hour, predominantly obstructive
Age 18 or older
Actively enrolled in an exercise and caloric reduction program
Not using Zepbound concurrently with a GLP-1 receptor agonist

Plus any one of:

BMI >= 30 kg/m2
Asian patient with BMI >= 27.5 kg/m2

Initial OSA approval — PAP therapy condition

All of:

All other OSA initial criteria met

Plus any one of:

Persistent OSA symptoms despite PAP adherence (at least 4 hours per night on at least 70% of nights)
Clinical documentation that patient is not a candidate for PAP
Clinical documentation that patient is intolerant of PAP

Documentation to bring

Documentation of moderate to severe OSA diagnosis
AHI/RDI/REI result showing >= 15 events per hour that is predominantly obstructive
Documentation of BMI >= 30 kg/m2 (or >= 27.5 kg/m2 for Asian patients)
Documentation of active enrollment in exercise and caloric reduction program
Documentation of persistent OSA symptoms despite PAP adherence (>=4 hours/night on >=70% of nights) OR clinical documentation of ineligibility or intolerance to PAP
Confirmation that Zepbound will not be used concurrently with a GLP-1 receptor agonist

Approval and renewal

To renew, the plan looks for Patient must have achieved or maintained a reduction in AHI/RDI/REI by at least 15 events per hour OR by at least 50%. Concurrent GLP-1 receptor agonist use remains prohibited at renewal.

Not covered when

Concurrent use of a GLP-1 receptor agonist (liraglutide, semaglutide, exenatide, exenatide extended-release)

Policy note: OSA must be predominantly obstructive. PAP adherence is defined as at least 4 hours per night on at least 70% of nights. At renewal, AHI/RDI/REI must be reduced by at least 15 events per hour OR by at least 50% from baseline. Age and lifestyle program enrollment requirements from initial criteria are not explicitly re-verified at renewal per the renewal criteria text; only the AHI/RDI/REI improvement and no concurrent GLP-1 use are listed as renewal requirements.

Policy effective June 1, 2026 · verified June 5, 2026 · source: Standard-Commercial-Guidelines-6-1-26-EXCERPTED.pdf

Kaiser Permanente Northern California coverage for Zepbound (Osa)